The worldwide problem of visual impairment is set to increase, as we are seeing increased longevity in developed countries. This will produce a crisis in vision care unless concerted action is taken.     The substantial value that ophthalmic interventions confer to patients with eye diseases has led to intense research efforts in this area in recent years, with corresponding improvements in treatment, ophthalmic instrumentation and surgical techniques. As a result, the future for ophthalmology holds great promise as further exciting and innovative developments unfold.

The global issue of visual impairment is expected to worsen as life expectancy increases in developed countries. This could lead to a crisis in vision care unless coordinated action is taken. The significant value that ophthalmic interventions provide to patients with eye diseases has spurred intense research efforts in this field in recent years, resulting in corresponding improvements in treatment, ophthalmic instrumentation, and surgical techniques. Consequently, the future of ophthalmology holds great promise as exciting and innovative developments continue to unfold.

随着发达国家人均寿命的延长，全球视觉障碍问题将日益严重。如果不采取协调一致的行动，这将导致视觉护理危机。近年来，眼科干预措施为眼病患者带来的显著价值，促使了该领域的深入研究，相关的治疗、眼科仪器和外科技术也得到了相应的改善。因此，眼科学的未来充满希望，随着更多令人兴奋和创新的发展不断涌现。

Expert Review of Ophthalmology

Introduction Ocular toxoplasmosis appears after primary infection or during the reactivation of chronic infection by the protozoa Toxoplasma gondii. The risk of ocular involvement and the heterogeneity of clinical manifestations, their complications, and the probability of recurrences are linked to polymorphisms in immune response-related genes, cytokine networks, lymphocyte subpopulation, and parasite virulence factors. Appropriate clinical management and evidence-based advisory recommendations for patients require a clear understanding of the immunopathological mechanisms of this parasitic disease.

Jorge Gomez Marin

Alejandra de la Torre

Mónica Vargas-Montes

Immunopathogenesis of ocular toxoplasmosis and implications for treatment

眼弓形虫病的免疫发病机制及其对治疗的启示

Thomas Chester

Roberta Longo

Cristina Masseria

Phoenix Riley

Chad Patel

Lorie Mody

Budget impact analysis (BIA) of the TearCare System for the treatment of meibomian gland dysfunction (mgd)-associated dry eye disease (DED) in the United States (US)

美国用于治疗与睑板腺功能障碍(mgd)相关干眼病(DED)的TearCare系统预算影响分析(BIA)

KEYWORDS: α-adrenergic receptorbrimonidine tartrateocular rednessophthalmic vasoconstrictorsrebound rednesstachyphylaxis

Melissa Toyos

Rolando Toyos

Real-world safety data for brimonidine tartrate: is there potential for overuse?

酒石酸布托尼啶的实际安全性数据：是否存在滥用风险？

Helen Song

Jack Begley

Collin Asheim

Thomas A. Albini

Christopher D. Conrady

Steven Yeh

Clinical, molecular, and immunologic mechanisms of CMV retinitis: evolving understanding in HIV and non-hiv immunosuppressed patients

巨细胞病毒性视网膜炎的临床、分子及免疫机制：HIV与非HIV免疫抑制患者认识的演变

Hyalocytes are sentinel macrophages residing within the posterior vitreous cortex anterior to the retinal inner limiting membrane (ILM). Following anomalous PVD and vitreoschisis, hyalocytes contribute to paucicellular (vitreo-macular traction syndrome, macular holes) and hypercellular (macular pucker, proliferative vitreo-retinopathy, proliferative diabetic vitreo-retinopathy) diseases.

Charlotte H. Jones

Wei Gui

Ricarda G. Schumann

Stefaniya K. Boneva

Clemens A. K. Lange

Koen A. van Overdam

Toco Y. P. Chui

Richard B. Rosen

Michael Engelbert

J. Sebag

Hyalocytes in proliferative vitreo-retinal diseases

增殖性玻璃体视网膜病变中的玻璃体细胞

Jacqueline Denise Humphreys

Yali Jia

Elizabeth Pearce

Plain language summary: the strengths and challenges of optical coherence tomography angiography (OCTA) in diabetic retinopathy

简明语言总结：光学相干断层血管成像（OCTA）在糖尿病视网膜病变中的优势与挑战

Charles W. McMonnies

The pervasive contributions of blink inefficiency to dry eye disease and computer vision syndromes

眨眼效率低下对干眼症和电脑视觉综合征的普遍影响

Abbreviation	Expert Rev. Ophthalmol.
Journal Impact	0.95
Quartiles(Global)	OPHTHALMOLOGY(Q4)

ISSN	1746-9899
h-index	31

Publication Information	Publisher: Taylor and Francis Ltd.，Publishing cycle: ，Journal Type: journal，Open Access Journals: No
Basic data	Year of publication: 2006，Proportion of original research papers: 42.50%，Self Citation Rate:11.10%， Gold OA Rate: 11.21%

Expert Review of Ophthalmology

Journal Citation Format

A journal article with 1 author

A journal article with 2 authors

A journal article with 3 authors

A journal article with 5 or more authors

Books Citation Format

Thesis Citation Format

Web sites Citation Format

Patent Citation Format

Staying up late manually editing references? ivySCI automatically matches journals and helps you generate references with a single click.

Share Submission Experience

Immunopathogenesis of ocular toxoplasmosis and implications for treatment

Budget impact analysis (BIA) of the TearCare System for the treatment of meibomian gland dysfunction (mgd)-associated dry eye disease (DED) in the United States (US)

Real-world safety data for brimonidine tartrate: is there potential for overuse?

Clinical, molecular, and immunologic mechanisms of CMV retinitis: evolving understanding in HIV and non-hiv immunosuppressed patients

Hyalocytes in proliferative vitreo-retinal diseases

Budget impact analysis (BIA) of the TearCare System for the treatment of meibomian gland dysfunction (mgd)-associated dry eye disease (DED) in the United States (US)

Real-world safety data for brimonidine tartrate: is there potential for overuse?

Clinical, molecular, and immunologic mechanisms of CMV retinitis: evolving understanding in HIV and non-hiv immunosuppressed patients

Plain language summary: the strengths and challenges of optical coherence tomography angiography (OCTA) in diabetic retinopathy

The pervasive contributions of blink inefficiency to dry eye disease and computer vision syndromes